GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 137 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2017. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $969,000 | -45.8% | 31,200 | -52.3% | 1.38% | -10.1% |
| Q2 2017 | $1,787,000 | -6.7% | 65,350 | +25.7% | 1.53% | -14.4% |
| Q1 2017 | $1,916,000 | +340.5% | 52,000 | +72.8% | 1.79% | +281.2% |
| Q4 2016 | $435,000 | -37.3% | 30,100 | 0.0% | 0.47% | -29.7% |
| Q3 2016 | $694,000 | +39.1% | 30,100 | 0.0% | 0.67% | +27.0% |
| Q2 2016 | $499,000 | – | 30,100 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $68 | 0.00% |